BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16038874)

  • 1. CO
    Smits JAJ; Monfils MH; Otto MW; Telch MJ; Shumake J; Feinstein JS; Khalsa SS; Cobb AR; Parsons EM; Long LJ; McSpadden B; Johnson D; Greenberg A;
    BMC Psychiatry; 2022 Dec; 22(1):831. PubMed ID: 36575425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapting cognitive-behavioral therapy for a Malaysian muslim.
    Subhas N; Mukhtar F; Munawar K
    Med J Islam Repub Iran; 2021; 35():28. PubMed ID: 34169040
    [No Abstract]   [Full Text] [Related]  

  • 3. Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.
    Bokma WA; Wetzer GAAM; Gehrels JB; Penninx BWJH; Batelaan NM; van Balkom ALJM
    Depress Anxiety; 2019 Sep; 36(9):801-812. PubMed ID: 31231925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Treatment-Resistant Panic Disorder.
    Perna G; Caldirola D
    Curr Treat Options Psychiatry; 2017; 4(4):371-386. PubMed ID: 29238651
    [No Abstract]   [Full Text] [Related]  

  • 5. A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study.
    Seki Y; Nagata S; Shibuya T; Yoshinaga N; Yokoo M; Ibuki H; Minamitani N; Kusunoki M; Inada Y; Kawasoe N; Adachi S; Yoshimura K; Nakazato M; Iyo M; Nakagawa A; Shimizu E
    BMC Res Notes; 2016 Oct; 9(1):458. PubMed ID: 27717407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.
    Otto MW; McHugh RK; Kantak KM
    Clin Psychol (New York); 2010 Jun; 17(2):91-103. PubMed ID: 26855480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Developments in Cognitive-Behavioral Therapy for Social Anxiety Disorder.
    Stangier U
    Curr Psychiatry Rep; 2016 Mar; 18(3):25. PubMed ID: 26830883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders.
    Ociskova M; Prasko J; Kamaradova D; Grambal A; Kasalova P; Sigmundova Z; Latalova K; Vrbova K
    Neuropsychiatr Dis Treat; 2015; 11():1191-201. PubMed ID: 26028972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of anxiety disorders: a critical review.
    Koen N; Stein DJ
    Dialogues Clin Neurosci; 2011; 13(4):423-37. PubMed ID: 22275848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of treatment-resistant panic disorder.
    Holt RL; Lydiard RB
    Psychiatry (Edgmont); 2007 Oct; 4(10):48-59. PubMed ID: 20428311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.
    Chavira DA; Stein MB; Golinelli D; Sherbourne CD; Craske MG; Sullivan G; Bystritsky A; Roy-Byrne PP
    J Nerv Ment Dis; 2009 Oct; 197(10):715-21. PubMed ID: 19829198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive behavior therapy in the treatment of panic disorder.
    Manjula M; Kumariah V; Prasadarao PS; Raguram R
    Indian J Psychiatry; 2009 Apr; 51(2):108-16. PubMed ID: 19823629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of panic disorder.
    Pull CB; Damsa C
    Neuropsychiatr Dis Treat; 2008 Aug; 4(4):779-95. PubMed ID: 19043522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of panic disorder.
    Marchesi C
    Neuropsychiatr Dis Treat; 2008 Feb; 4(1):93-106. PubMed ID: 18728820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
    Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
    BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission.
    Heldt E; Gus Manfro G; Kipper L; Blaya C; Isolan L; Otto MW
    Behav Res Ther; 2006 May; 44(5):657-65. PubMed ID: 16038874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behavior therapy for treatment-refractory panic disorder.
    Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
    J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.